Home > M&A deals 2008 > 3i Private Equity acquires Xellia Pharmaceuticals AS
Buyout (LBO, MBO, MBI) · Life Science · April 2008

3i Private Equity acquires Xellia Pharmaceuticals AS

On April 1, 2008, 3i Private Equity acquired Xellia Pharmaceuticals AS, a life science company in Norway.

Deal at a glance

AnnouncedApril 1, 2008 TypeBuyout (LBO, MBO, MBI) TargetXellia Pharmaceuticals AS Buyer 3i Private Equity SectorLife Science LocationNorway ValueMembers only

Target company

Xellia Pharmaceuticals AS
Norway
Xellia Pharmaceuticals is a fully integrated specialty pharmaceutical company focusing on the global anti-infective market.
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

3i Private Equity
Private equity firm · 308 deals on record
  • 5th transaction in life science
  • 3rd transaction in Norway
308deals, all time
7in this sector
2022latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

TempoSame lead buyer · Mar 2022

Questions about this deal

Who acquired Xellia Pharmaceuticals AS?3i Private Equity acquired Xellia Pharmaceuticals AS on April 1, 2008.

What type of deal was it?It was a buyout (lbo, mbo, mbi) in the life science sector in 2008.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).